Tenax Therapeutics Inc TENX

Healthcare Biotechnology

Tenax Therapeutics, Inc. is a Phase 3 development-stage pharmaceutical company. The Company is focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The Company's products include TNX-201 (oral enteric coated imatinib) and TNX-103 (oral levosimendan). The Company is developing dosing and a formulation of imatinib mesylate, a kinase inhibitor for the treatment of pulmonary arterial hypertension (PAH). The Company’s other programs include TNX-101 (IV), TNX-102 (subcutaneous) and TNX-103 (oral) levosimendan. Levosimendan is a calcium sensitizer/K-ATP activator developed for intravenous use in hospitalized patients with acutely decompensated heart failure. The Company has completed the Phase II trial of levosimendan in patients with PH and heart failure with preserved ejection fraction (HFpEF).

NDAQ:TENX - Post by User

Tenax Therapeutics Inc > TENX ....I've had this on my "to buy" list

<< Previous

Bullboard Posts

Next >>

Post by Iseneschalon Jan 29, 2024 11:02am

36 Views

Post# 35850384

TENX ....I've had this on my "to buy" list

No position....currently at $13.25

Wouldn't buy it now because .......No Volume

It's up on low volume...this could easily reverse on low volume

Just my 2 bits

There's always another ; )

<< Previous

Bullboard Posts

Next >>

Multi-bagger industrial stock adds $90M in new contracts